who is nervous?, page-11

First 11 Last

Share
Profile

Follow
mika121

744 Posts.

164

14/03/20

21:32

Post #: 43497088
Share

Originally posted by NewbieHK: ↑

Nothing like a correction -> bear market to have everyone question the shares they own...like we all should. As mentioned by @orsinga it as yet to turn a profit and still speculative even though the signs are there it could turn into a nice little business.

@karmadog12 the joys of riding the wave of a micro-cap.

@orsinga what a load of rubbish. The RADI is just as valuable previously as it will be when it's awarded.

@mika121 the original application was only submitted at the end of 2018. I am not sure why you have been waiting since Nov 2018. It's also been clearly stated that after feedback from the regulators last year they resubmitted again late last year. I would assume the application would need to be reviewed again in its entirety.

@ArtTar this is an interesting one and yes there may as you have pointed out be some issues in this area. Though, it's likely some will still need to pay their bills whether they are back or not. It also seems 25,000 or the 150,000 have managed to find their way into Australia by fulfilling a quarantine in other countries. Let's hope there is sufficient growth in other aspects to buffer potential short term revenue reductions from the Chinese students.

Expand

What do mean we haven't been waiting since November 2018 for the RADI to be approved ? You also said yourself the application fo the RADI was lodge in Nov 2018. Quite confusing indeed..
If it has been re-lodge after this date we still have been waiting since the initial application date.

NOV Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 4 more messages in this thread...

First 11 Last

Add NOV (ASX) to my watchlist

(20min delay)
Last 6.5¢		Change -0.006(8.45%)		Mkt cap ! $23.12M

Open	High	Low	Value	Volume
6.6¢	6.7¢	6.4¢	$23.22K	361.4K

Buyers (Bids)

No.	Vol.	Price($)
1	48465	6.2¢

Sellers (Offers)

Price($)	Vol.	No.
6.9¢	100000	1

View Market Depth

No.	Vol.	Price($)
1	48465	0.062
1	40000	0.060
2	189303	0.056
3	90000	0.055
1	180000	0.054

Price($)	Vol.	No.
0.069	100000	1
0.070	50000	1
0.079	38710	1
0.080	235399	3
0.081	1850	1

Last trade - 15.59pm 07/10/2024 (20 minute delay)

NOV (ASX) Chart

who is nervous?, page-11

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

who is nervous?, page-11

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News